AB
ALXN
AT Bancorp’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $1.04M | Sell |
7,694
-82
| -1% | -$11.1K | 0.13% | 96 |
|
|
2018
Q4 | $757K | Buy |
7,776
+1,462
| +23% | +$142K | 0.1% | 111 |
|
|
2018
Q3 | $877K | Sell |
6,314
-2,346
| -27% | -$326K | 0.09% | 113 |
|
|
2018
Q2 | $1.08M | Sell |
8,660
-5,789
| -40% | -$719K | 0.12% | 99 |
|
|
2018
Q1 | $1.61M | Buy |
14,449
+792
| +6% | +$88.3K | 0.17% | 72 |
|
|
2017
Q4 | $1.63M | Buy |
13,657
+8,813
| +182% | +$1.05M | 0.18% | 73 |
|
|
2017
Q3 | $679K | Buy |
4,844
+981
| +25% | +$138K | 0.08% | 125 |
|
|
2017
Q2 | $470K | Sell |
3,863
-4,671
| -55% | -$568K | 0.06% | 165 |
|
|
2017
Q1 | $3.09M | Buy |
+8,534
| New | +$3.09M | 0.4% | 47 |
|
|
2016
Q4 | – | Sell |
-8,992
| Closed | -$1.1M | – | 268 |
|
|
2016
Q3 | $1.1M | Buy |
+8,992
| New | +$1.1M | 0.15% | 147 |
|